Herbas VPB

Print
EN | LT
LT - INTERLEUKIN-13 RECEPTOR ALPHA 2 PEPTIDE-BASED BRAIN CANCER VACCINES
EN - INTERLEUKIN-13 RECEPTOR ALPHA 2 PEPTIDE-BASED BRAIN CANCER VACCINES

Legal status

Patent not validated

Bibliographic data
Indications of the International Patent Classification (IPC)
(51) INT.CL. A61K 38/17 (2006.01)
A61K 9/0019 (2013.01)
A61K 9/00 (2006.01)
A61K 38/17 (2013.01)
C07K 14/705 (2006.01)
A61K 38/1709 (2013.01)
C07K 14/4703 (2013.01)
C07K 14/47 (2006.01)
A61P 25/00 (2006.01)
C07K 14/4705 (2013.01)
A61P 43/00 (2006.01)
C07K 14/705 (2013.01)
A61K 39/00 (2006.01)
C07K 14/7155 (2013.01)
C07K 14/715 (2006.01)
A61P 25/00 (2018.01)
A61P 35/00 (2006.01)
A61P 35/00 (2018.01)
A61P 37/04 (2006.01)
A61P 37/04 (2018.01)
A61P 43/00 (2018.01)
A61K 39/001122 (2018.08)
A61K 39/00115 (2018.08)
A61K 39/001119 (2018.08)
A61K 39/001192 (2018.08)
A61K 39/001153 (2018.08)
European patent
(11) Number of the document 3511013
(13) Kind of document T
(96) European patent application number 18211075.9
Date of filing the European patent application 2011-08-23
(97) Date of publication of the European application 2019-07-17
(45) Date of publication and mention of the grant of the patent 2022-09-07
(46) Date of publication of the claims translation
Priority applications
(30) Number Date Country code
37658210 P 2010-08-24 US
Inventors
(72)
Okada, Hideho , US
Grantee
(73) University of Pittsburgh - Of the Commonwealth System of Higher Education , 1st Floor Gardner Steel Conference Center 130 Thackeray Avenue, Pittsburgh, PA 15260, US
Title
(54) INTERLEUKIN-13 RECEPTOR ALPHA 2 PEPTIDE-BASED BRAIN CANCER VACCINES
  INTERLEUKIN-13 RECEPTOR ALPHA 2 PEPTIDE-BASED BRAIN CANCER VACCINES